Exercise tolerance measurements in pulmonary vascular diseases and chronic heart failure

Respiration

Volumn 77, Issue 3, 2009, Pages 241-251

  Piepoli, Massimo F ^a  

^a Guglielmo da Saliceto Polichirurgico Hospital   (Italy)

Author keywords

Cardiopulmonary exercise test; Chronic heart failure; Pulmonary vascular diseases

Indexed keywords

ARTICLE; CARDIOPULMONARY EXERCISE TEST; CLINICAL DECISION MAKING; DYSPNEA; EXERCISE TOLERANCE; FATIGUE; FUNCTIONAL STATUS; HEALTH STATUS; HEART FAILURE; HEART FUNCTION; HUMAN; LUNG FUNCTION; LUNG GAS EXCHANGE; LUNG VENTILATION; PERFORMANCE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PULMONARY VASCULAR DISEASE;

EXERCISE TEST; EXERCISE TOLERANCE; HEART FAILURE; HUMANS; LUNG DISEASES; PULMONARY GAS EXCHANGE; RESPIRATORY FUNCTION TESTS;

EID: 64349116233     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000203697     Document Type: Article

References (60)

1. Nieminen MS, Bohm M, Cowie MR, et al: Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26: 384-416.
2. Ansari M, Massie BM: Heart failure: how big is the problem? Who are the patients? What does the future hold? Am Heart J 2003; 146: 1-4.
3. Ferrazza AM, Martolini D, Valli G, Palange P: Cardiopulmonary exercise testing in the functional and prognostic evaluation of patients with pulmonary diseases. Respiration 2009; 77: 3-17.
4. Garrard CS, Emmons C: The reproducibility of the respiratory responses to maximum exercise. Respiration 1986; 49: 94-100.
5. Piepoli MF, Corrà U, Agostoni PG, Belardinelli R, Cohen-Solal A, Hambrecht R, Vanhees L: Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction: recommendations for performance and interpretation. Part I. Eur J Cardiovasc Prev Rehabil 2006; 13: 150-164.
6. Piepoli MF, Corrà U, Agostoni PG, Belardinelli R, Cohen-Solal A, Hambrecht R, Vanhees L: Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction: recommendations for performance and interpretation. Part II. Eur J Cardiovasc Prev Rehabil 2006; 13: 585-594.
7. Piepoli MF, Corrà U, Agostoni PG, Belardinelli R, Cohen-Solal A, Hambrecht R, Vanhees L: Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction: recommendations for performance and interpretation. Part III. Eur J Cardiovasc Prev Rehabil 2006; 13: 782-796.
8. Wilson RC, Jones PW: Long-term reproducibility of Borg scale estimates of breathlessness during exercise. Clin Sci 1991; 80: 309-312.
9. Meyer K, Westbrook S, Schwaibold M, Hajric R, Peters K, Roskamm H: Short-term reproducibility of cardiopulmonary measurements during exercise testing in patients with severe chronic heart failure. Am Heart J 1997; 134: 20-26.
10. Myers J, Walsh D, Buchanan N, Froelicher VF: Can maximal cardiopulmonary capacity be recognized by a plateau in oxygen uptake? Chest 1989; 96: 1312-1316.
11. Committee on Exercise Testing: ACC/AHA Guidelines Update for Exercise Testing: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2002; 40: 1531-1540. www.americanheart.org.
12. Corra U, Mezzani A, Bosimini E, Giannuzzi P: Cardiopulmonary exercise testing and prognosis in chronic heart failure: a prognosticating algorithm for the individual patient. Chest 2004; 126: 942-950.
13. Cohen-Solal A, Laperche T, Morvan D, Geneves M, Caviezel B, Gourgon R: Prolonged kinetics of recovery of oxygen consumption and ventilatory variables after maximal graded exercise in patients with chronic heart failure. Analysis with gas exchange and NMR spectroscopy study. Circulation 1995; 91: 2924-2932.
14. Sullivan CS, Casaburi R, Storer TW, Wasserman K: Non-invasive prediction of blood lactate response to constant power outputs from incremental exercise tests. Eur J Appl Physiol Occup Physiol 1995; 71: 349-354.
15. European Respiratory Society: Clinical exercise testing with reference to lung diseases: indications, standardization and interpretation strategies. ERS Task Force on Standardization of Clinical Exercise Testing. Eur Respir J 1997; 10: 2662-2689.
16. Myers J, Gullestad L, Vagelos R, Do D, Bellin D, Ross H, Fowler MB: Clinical, hemodynamic, and cardiopulmonary exercise test determinants of survival in patients referred for evaluation of heart failure. Ann Intern Med 1998; 129: 286-293.
17. Gitt AK, Wasserman K, Kilkowski C, et al: Exercise anaerobic threshold and ventilatory efficiency identify heart failure patients for high risk of early death. Circulation 2002; 106: 3079-3084.
18. Casaburi R, Porszasz J, Burns MR, Carithers ER, Chang RS, Cooper CB: Physiologic benefits of exercise training in rehabilitation of patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 155: 1541-1551.
19. American Association of Cardiovascular and Pulmonary Rehabilitation. Pulmonary rehabilitation: joint ACCP/AACVPR evidence- based guidelines. ACCP/AACVPR Pulmonary Rehabilitation Guidelines Panel. Chest 1997; 112: 1363-1396.
20. Opasich C, Pinna GD, Bobbio M, et al: Peak exercise oxygen consumption in chronic heart failure: toward efficient use in the individual patient. J Am Coll Cardiol 1998; 31: 766-775.
21. Collins JV, Clark TJH, Brown DJ: Airway function in healthy subjects and patients with left heart disease. Clin Sci Mol Med 1975; 49: 217-228.
22. Wright RS, Levine MS, Bellamy PE, Simmons MS, Batra P, Stevenson LW: Ventilatory and diffusion abnormalities in potential heart transplant recipients. Chest 1990; 98: 816-820.
23. Ewert R, Wensel R, Bettmann M, Spiegelsberger S, Grauhan O, Hummel M, Hetzer R: Ventilatory and diffusion abnormalities in long-term survivors after orthotopic heart transplantation. Chest 1999; 115: 1305-1311.
24. Agostoni P, Pellegrino R, Conca C, Rodarte JR, Brusasco V: Exercise in chronic heart failure: relationships to lung stiffness and expiratory flow limitation. J Appl Physiol 2002; 92: 1409-1416.
25. Agostoni P, Cattadori G, Guazzi M, Melzi G, Lomanto M, De Vita S, Pontone G, Bussotti M, Marenzi GC: Cardiomegaly as a possible cause of lung dysfunction in heart failure patients. Am Heart J 2000; 140:E24.
26. Frank NR, Lyons HA, Siebens AA, Nealon TF: Pulmonary compliance in patients with cardiac disease. Am J Med 1957; 22: 516-521.
27. Ries AL, Gregoratos G, Friedman PJ, Clausen JL: Pulmonary function test in the detection of left heart failure: correlation with pulmonary artery wedge pressure. Respiration 1986; 49: 241-250.
28. Faggiano P, Lombardi C, Sorgato A, Ghizzoni G, Spedini C, Rusconi C: Pulmonary function tests in patients with congestive heart failure: effects of medical therapy. Cardiology 1993; 83: 30-35.
29. Hosenpud JD, Stibolt TA, Atwal K, Shelley D: Abnormal pulmonary function specifically related to congestive heart failure: comparison of patients before and after cardiac transplantation. Am J Med 1990; 88: 493-496.
30. Ravenscraft SA, Gross CR, Kubo SH, Olivari MT, Shunway SJ, Bolman RE III, Hertz MI: Pulmonary function after successful heart transplantation. Chest 1993; 103: 54-58.
31. Gazetopoulos N, Davies H, Oliver C, Deuchar D: Ventilation and haemodynamics in heart disease. Br Heart J 1966; 28: 1-15.
32. Szidon JP: Pathophysiology of the congested lung. Cardiol Clin 1989; 7: 39-48.
33. Clark AL, Davies LC, Francis DP, Coats AJS: Ventilatory capacity in patients with chronic stable heart failure. Eur J Heart Fail 2000; 2: 47-51.
34. Roughton FJ, Forster FE: Relative importance of diffusion and chemical reaction rates in determining rate of exchange of gases in human lung, with special reference to true diffusing capacity of blood in the lung capillaries. J Appl Physiol 1957; 11: 290-302.
35. Puri S, Baker BL, Oakley CM, Hughes JMB, Cleland JG: Increased alveolar/capillary membrane resistance to gas transfer in patients with chronic heart failure. Br Heart J 1994; 72: 140-144.
36. Guazzi M: Alveolar-capillary membrane dysfunction in chronic heart failure: pathophysiology and therapeutic implications. Clin Sci 2000; 98: 633-641.
37. Agostoni P, Magini A, Andreini D, Contini M, Apostolo A, Bussotti M, Cattadori G, Palermo P: Spironolactone improves lung diffusion in chronic heart failure. Eur Heart J 2005; 26: 159-164.
38. Agostoni P, Bussotti M, Palermo P, Guazzi M: Does lung diffusion impairment affect exercise capacity in patients with heart failure? Heart 2002; 88: 453-459.
39. Puri S, Baker BL, Dutka DP, Oakley CM, Hughes JMB, Cleland JG: Reduced alveolarcapillary membrane diffusing capacity in chronic heart failure: its pathophysiological relevance and relationship to exercise performance. Circulation 1995; 91: 2769-2777.
40. Agostoni P, Cattadori G, Bianchi M, Wasserman K: Exercise-induced pulmonary edema in heart failure. Circulation 2003; 108: 2666-2671.
41. Rubin SA, Brown HV: Ventilation and gas exchange during exercise in severe chronic heart failure. Am Rev Respir Dis 1984; 129: S63-S64.
42. Wasserman K: Normal values, physiologic dead space/tidal volume ratio; in Wasserman K, Hansen JE, Sue DY, Casaburi R, Whipp BJ: Principles of Exercise Testing and Interpretation. Baltimore, Lippincott Williams & Wilkins, 1999, pp 157-158.
43. Metra M, Dei Cas L, Panina G, Visioli O: Exercise hyperventilation chronic congestive heart failure, and its relation to functional capacity and hemodynamics. Am J Cardiol 1992; 70: 622-628.
44. Reindl I, Wernecke KD, Opitz C, et al: Impaired ventilatory efficiency in chronic heart failure: possible role of pulmonary vasoconstriction. Am Heart J 1998; 136: 778-785.
45. Tanabe Y, Hosaka Y, Ito M, et al: Significance of end-tidal P(CO(2)) response to exercise and its relation to functional capacity in patients with chronic heart failure. Chest 2001; 119: 811-817.
46. Clark AL, Poole-Wilson PA, Coats AJ: Exercise limitation in chronic heart failure: central role of the periphery. J Am Coll Cardiol 1996; 28: 1092-1102.
47. Ponikowski P, Francis DP, Piepoli MF, et al: Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis. Circulation 2001; 103: 967-972.
48. Chua TP, Ponikowski P, Harrington D, et al: Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 1997; 29: 1585-1590.
49. Francis DP, Shamin W, Ceri Davies L, et al: Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/ V CO 2 slope and peak V O 2 . Eur Heart J 2002; 21: 154-161.
50. Agostoni P, Guazzi M, Bussotti M, De Vita S, Palermo P: Carvedilol reduces the inappropriate increase of ventilation during exercise in heart failure patients. Chest 2002; 122: 2062-2067.
51. Arena R, Humphrey R, Peberdy MA: Prognostic ability of VE/V CO 2 slope calculations using different exercise test time intervals in subjects with heart failure. Eur J Cardiovasc Prev Rehabil 2003; 10: 463-468.
52. Tabet JY, Beauvais F, Thabut G, Tartiere JM, Logeart D, Cohen-Solal A: A critical appraisal of the prognostic value of the VE/V CO 2 slope in chronic heart failure. Eur J Cardiovasc Prev Rehabil 2003; 10: 267-272.
53. Baba R, Nagashima M, Goto M, Nagano Y, Yokota M, Tauchi N, Nishibata K: Oxygen uptake efficiency slope: a new index of cardiorespiratory functional reserve derived from the relation between oxygen uptake and minute ventilation during incremental exercise. J Am Coll Cardiol 1996; 28: 1567-1572.
54. Kremser CB, O'Toole MF, Leff AR: Oscillatory hyperventilation in severe congestive heart failure secondary to idiopathic dilated cardiomyopathy or to ischemic cardiomyopathy. Am J Cardiol 1987; 59: 900-905.
55. Piepoli MF, Ponikowski PP, Volterrani M, Francis D, Coats AJ: Aetiology and pathophysiological implications of oscillatory ventilation at rest and during exercise in CHF. Do Cheyne and Stokes have an important message for modern-day patients with heart failure? Eur Heart J 1999; 20: 946-953.
56. Corrà U, Giordano A, Bosimini E, Mezzani A, Piepoli M, Coats AJ, Giannuzzi P: Oscillatory ventilation during exercise in patients with chronic heart failure. Clinical correlates and prognostic implications. Chest 2002; 121: 1572-1580.
57. Stringer WW, Hansen JE, Wasserman K: Cardiac output estimated noninvasively from oxygen uptake during exercise. J Appl Physiol 1997; 82: 908-912.
58. Perloff D, Grim C, Flack J, Frohlich ED, Hill M, McDonald M, Morgenstern B: Human blood pressure determination by sphygmomanometry. Circulation 1993; 88: 2460-2470.
59. Piepoli M, Clark AL, Volterrani M, Adamopoulos S, Sleight P, Coats AJ: Contribution of muscle afferents to the hemodynamic, autonomic, and ventilatory responses to exercise in patients with chronic heart failure: effects of physical training. Circulation 1996; 93: 940-952.
60. Osada N, Chaitman BR, Miller LW, Yip D, Cishek MB, Wolford TL, Donohue TJ: Cardiopulmonary exercise testing identifies low risk patients with heart failure and severely impaired exercise capacity considered for heart transplantation. J Am Coll Cardiol 1998; 31: 577-582.